Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provided today details of its plans to report second quarter 2020 financial results…
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provided today details of its plans to report second quarter 2020 financial results…
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provided today details of its plans to report second quarter 2020 financial results…
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provided today details of its plans to report second quarter 2020 financial results…
Earned a top score for the second year in a row IRVING, Texas–(BUSINESS WIRE)–McKesson today announced that The Disability Equality…
Earned a top score for the second year in a row IRVING, Texas–(BUSINESS WIRE)–McKesson today announced that The Disability Equality…
Earned a top score for the second year in a row IRVING, Texas–(BUSINESS WIRE)–McKesson today announced that The Disability Equality…
Earned a top score for the second year in a row IRVING, Texas–(BUSINESS WIRE)–McKesson today announced that The Disability Equality…
BAFIERTAM™ (monomethyl fumarate), a novel fumarate with a similar profile as Vumerity®, will be commercially available September 1, 2020 HIGH…
BAFIERTAM™ (monomethyl fumarate), a novel fumarate with a similar profile as Vumerity®, will be commercially available September 1, 2020 HIGH…